Skip to main content
. 2019 Jun 21;10(4):1535–1541. doi: 10.1007/s13300-019-0654-y

Fig. 2.

Fig. 2

The 24-h glucose variations based on continuous glucose monitoring of patients with a pre-prandial glucose level of approximately 100 mg/dl at breakfast (n = 8). Solid and dotted lines show the glucose variations in patients receiving insulin glargine 300 U/ml (Gla300) and degludec (Deg), respectively